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A B S T R A C T
The aim of this study was to investigate isolates of Actinobacillus pleuropneumoniae previously designated ser-
ologically either as non-typable (NT) or as ‘K2:07’, which did not produce serovar-specific amplicons in PCR
assays.
We used whole genome sequencing to identify the capsule (CPS) loci of six previously designated biovar 1 NT
and two biovar 1 ‘K2:O7’ isolates of A. pleuropneumoniae from Denmark, as well as a recent biovar 2 NT isolate
from Canada. All of the NT isolates have the same six-gene type I CPS locus, sharing common cpsABC genes with
serovars 2, 3, 6, 7, 8, 9, 11 and 13. The two ‘K2:O7’ isolates contain a unique three-gene type II CPS locus, having
a cpsA gene similar to that of serovars 1, 4, 12, 14 and 15. The previously NT isolates share the same O-antigen
genes, found between erpA and rpsU, as serovars 3, 6, 8, and 15. Whereas the ‘K2:O7’ isolates, have the same O-
antigen genes as serovar 7, which likely contributed to their previous mis-identification. All of the NT and
‘K2:O7’ isolates have only the genes required for production of ApxII (apxIICA structural genes, and apxIBD
export genes).
Rabbit polyclonal antisera raised against representative isolates with these new CPS loci demonstrated dis-
tinct reactivity compared to the 16 known serovars. The serological and genomic results indicate that the isolates
constitute new serovars 17 (previously NT) and 18 (previously ‘K2:O7’). Primers designed for amplification of
specific serovar 17 and 18 sequences for molecular diagnostics will facilitate epidemiological tracking of these
two new serovars of A. pleuropneumoniae.
1. Introduction
Actinobacillus pleuropneumoniae is a member of the Pasteurellaceae
family, and an important respiratory pathogen of swine. Economic
losses in the swine industry worldwide are due to mortality associated
with acute disease, and the medication cost for treatment and reduced
production associated with chronic pleuropneumonia (Sassu et al.,
2017). Approaches to controlling the disease include good husbandry/
biosecurity and vaccination to reduce incidence, and in the face of
clinical disease, treatment with antibiotics to limit severity and spread
(Sassu et al., 2017).
It is useful to classify isolates of A. pleuropneumoniae not only for
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epidemiological purposes, but also to inform vaccine development
(Gottschalk, 2012). Broadly, isolates can be separated into two biovars,
with the more prevalent biovar 1 type requiring exogenous nicotina-
mide adenine dinucleotide (NAD) for growth, and biovar 2 being NAD-
independent (Pohl et al., 1983; Maldonado et al., 2009). Isolates can be
further differentiated into serovars, based mainly on capsule (CPS)
antigens (Perry et al., 1990; Dubreuil et al., 2000), and 16 serovars are
currently recognized (Sárközi et al., 2015; Bossé et al., 2017a).
With improved molecular diagnostics, including whole genome se-
quencing, it is possible to re-evaluate previously non-typable (NT)
isolates, as well as those which present unusual serological or molecular
diagnostic results. Recently, Morioka et al. (2016) showed that the
methods of antigen preparation and serological testing, could influence
the results for identification of certain serovars. Specifically, autoclaved
antigens of forty-seven isolates proved un-typable in the agar gel dif-
fusion assay, whereas rapid slide agglutination using formalin-fixed
antigens identified all but two isolates as serovars 1, 2 or 15. The CPS
types were confirmed by multiplex PCRs (mPCRs) (Bossé et al., 2014;
Turni et al., 2014; Ito, 2010), with the two remaining serologically NT
isolates producing specific amplicons for serovars 2 and 15. Not all
isolates of a given serovar were identified by all of the available mPCRs.
The reason for the discrepancy between molecular and serological
typing for these two isolates was not investigated; however it is possible
that the presence of a transposon insertion in one of the biosynthetic or
export genes resulted in no serologically detectable CPS being pro-
duced. This was recently shown by Ito et al. (2016) who found that the
presence of ISApl1 insertions in the CPS loci of two isolates with serovar
15-specific capsule genes rendered them serologically NT.
The aim of this study was to investigate isolates of A. pleur-
opneumoniae previously designated serologically either as NT or as
‘K2:07’, but which did not amplify serovar-specific amplicons in mPCRs
(Jessing et al., 2003; Schuchert et al., 2004; Angen et al., 2008), by
whole genome sequencing in order to determine the molecular orga-
nization of their CPS biosynthetic loci. Our results demonstrate the
existence of two new serovars, 17 and 18, of A. pleuropneumoniae.
2. Materials and methods
2.1. Clinical A. pleuropneumoniae isolates used in this study
Information regarding the proposed serovar 17 and 18 A. pleur-
opneumoniae isolates sequenced in this study is shown in Table 1. The
Danish biovar 1 isolates previously designated as serologically NT were
shown to belong to a distinct phylogenetic cluster (c17) by amplified
fragment length polymorphism (AFLP), and were all recovered from
pigs on the same farm (Kokotovic and Angen, 2007). Those designated
as ‘K2:O7’ (also biovar 1) had been typed serologically by latex ag-
glutination, but showed no serovar-specific bands when tested by mPCR
(Angen et al., 2008; Jessing et al., 2003; Schuchert et al., 2004). The
Canadian biovar 2 isolate, 14-022, recovered from the pneumonic lung
of a pig in Ontario in 2014, was also found to be NT by serological and
molecular methods (Bossé et al., 2014). Information regarding nine
additional isolates typed as serovar 17 or 18 by PCR is shown in
Table 2. Of these, two of the ‘K2:O7’ isolates (15360/96 and 12323/98)
were previously reported to belong to the distinct AFLP phylogenetic
cluster, c11 (Kokotovic and Angen, 2007).
2.2. Genome sequencing and analysis
Genomic DNA was prepared from all isolates as previously de-
scribed (Bossé et al., 2015). The Microbes NG Sequencing Facility
(www.microbesng.uk) generated and assembled the whole genome
sequence of isolate 14-022; for all other samples, paired-end sequencing
(Illumina HiSeq 2000) was performed at the Wellcome Trust Sanger
Institute (Cambridge, UK), analysed, and assembled as previously de-
scribed (Bossé et al., 2017b; Howell et al., 2013; Weinert et al., 2015).
Genes of the CPS biosynthetic loci were identified in the draft
genomes of each isolate by searching, using BLASTn (http://blast.ncbi.
nlm.nih.gov/Blast.cgi), for the cpxD gene (accession AIA09380) from
the capsule export locus, common to all serovars. The identified loci
were analyzed using BLASTn and BLASTx. Multiple sequence align-
ments were performed using ClustalW in MacVector v15.5.2. Genes
encoding Apx toxin biosynthetic and export proteins were also identi-
fied by BLASTn using sequences of apxICABD and apxIICA from the L20
genome (accession number CP000569), and apxIIICABD from the JL03
genome (accession number CP000687). The O-antigen biosynthesis loci
were identified by tBLASTn using the erpA and rpsU genes (accession
numbers WP_005617946 and WP_005598703, respectively) to de-
lineate the flanking genes.
The sequences of the complete capsule loci for the serovar 17 and 18
isolates listed in Table 1 have been deposited in GenBank under ac-
cession numbers: MG780416 - MG780424.
Table 1
Proposed serovar 17 and 18 isolates of A. pleuropneumoniae sequenced in this study.
Strain ID Year Country Previous Designation Biovar Proposed Serovar Reference
16287-1 1997 Denmark NT 1 17 (Kokotovic and Angen, 2007)
17102-11 1997 Denmark NT 1 17 (Kokotovic and Angen, 2007)
10907-11 1998 Denmark NT 1 17 (Kokotovic and Angen, 2007)
11990-6 1998 Denmark NT 1 17 (Kokotovic and Angen, 2007)
11990-7 1998 Denmark NT 1 17 (Kokotovic and Angen, 2007)
17102-10 1997 Denmark NT 1 17 (Kokotovic and Angen, 2007)
14-022 2014 Canada NT 2 17 This study
7311555 2001 Denmark K2:O7 1 18 This study
7603757 2005 Denmark K2:O7 1 18 This study
Table 2
Additional A. pleuropneumoniae serovar 17 and 18 isolates identified by PCR.
Strain ID Year Country Previous
Designation
Biovar Serovar
by PCR
Reference
11-008-1 2008 Germany NT 1 18 This study
1055935 2011 Italy NT 1 18 This study
A05-0208 2016 USA NT 2 17 This study
16-006 2016 USA NT 2 17 This study
17-027 2017 USA NT 2 17 This study
APP199 2004 Spain NT 1 18 This study
4436 2017 Spain NT 1 18 This study
4443 2017 Spain 8 1 17 This study
4461 2018 Spain 8 1 17 This study
15360/96 1996 Denmark K2:O7 1 18 (Kokotovic
and Angen,
2007)
12323/98 1998 Denmark K2:O7 1 18 (Kokotovic
and Angen,
2007)
10374/02 2002 Denmark K2:O7 1 18 (Kokotovic
and Angen,
2007)
J.T. Bossé et al. Veterinary Microbiology 217 (2018) 1–6
2
2.3. Production of antisera
Hyperimmune rabbit polyclonal antisera were raised against for-
malin-killed preparations of isolates 16287-1 (Danish NT; proposed
reference strain for serovar 17) and 7311555 (Danish ‘K2:O7’; proposed
reference strain for serovar 18), as previously described (Sárközi et al.,
2015).
2.4. Serological testing
Indirect hemagglutionation (IHA) was performed using antisera
raised against the 16 recognised serovars, as well as the new antisera
raised in this study, as previously described (Sárközi et al., 2015).
2.5. Diagnostic PCRs
Primers AP17F (TTGTAATGGCGGTGTAATGCTAC) and AP17R
(CATAAGTGCAGCCATCTCTTTCAG) were designed to amplify a 302 bp
serovar 17-specific amplicon; and primers AP18F (CGGAGTTTGGCAG
CATAAAGG) and AP18R (CCATAATCGGTGCTCAACTAAGAATG) were
designed to amplify a 514 bp fragment of the serovar 18-specific am-
plicon (see Fig. 1 for locations of primers). These primers were com-
bined, along with those previously designed (Bossé et al., 2014) for
detection of the 418 bp apxIV band common to all serovars, and were
initially tested using genomic DNA from the one Canadian and six
Danish NT isolates (for serovar 17), and the two Danish ‘K2:O7’ isolates
(for serovar 18), shown in Table 1, as well as the reference strains for
the 16 known serovars strains (i.e. 4074T, 1536, S1421, M62, K17, L20,
Femø, WF83, 405, CVJ13261, D13039, 56153, 8328, N-273, 3906,
HS143, and A-85/14, respectively). Subsequently, the specificity of the
primers was further evaluated using the same 68 clinical isolates of A.
pleuropneumoniae (covering serovars 1–15), the six A. pleuropneumoniae
serovar 16 isolates, and the 31 porcine-associated species recently used
for evaluation of serovar 16-specific primers (Bossé et al., 2017a), as
well as the nine clinical isolates shown in Table 2.
3. Results and discussion
The serovar 17 isolates (Table 1; proposed reference strain 16287-1)
encode a type I CPS locus (Fig. 1A), with the first three genes
(cps17ABC) encoding a glycerol transferase, a glycerol-3-phosphate
cytidylyltransferase, and a hypothetical protein, respectively, with high
identity to those encoded by the first three genes in the loci of serovars
2, 3, 6, 7, 8, 9, 11 and 13 (Xu et al., 2010; Bossé et al., 2014). The
serovar 17 CPS locus most closely resembles that of serovar 8, with 99%
identity at the nucleotide level between the sequences cps17ABCDE and
cps8ABCDE (Fig. 1A). The cpsDE genes in both these serovars encode the
same predicted glycosyltransferases. We previously reported (Bossé
et al., 2014) that the CPS locus of the serovar 8 reference strain, 405,
was comprised of these five genes. However, upon further analysis of
the sequences downstream of the cpsE gene in the draft genome se-
quence of strain 405, and in the complete genome sequence of
MIDG2331 (Bossé et al., 2016), a further three ORFs encoding hy-
pothetical proteins (MIDG2331_01764, MIDG2331_01763, and
MIDG2331_01762) are present that may also be part of the CPS bio-
synthetic locus, though the function of these proteins has yet to be
determined.
In the serovar 17 CPS locus, the first five genes are followed by a
single ORF (cps17F) predicted to encode a hypothetical protein con-
taining a DUF1919 superfamily domain (involved in cell wall/mem-
brane/envelope biogenesis) in the N-terminal portion of the sequence.
The first 197 amino acids (AAs) of the Cps17F sequence shares 54%
identity with a predicted expolysaccharide biosynthesis protein (206
AA) encoded by a gene divergently transcribed from that encoding
phosphomanomutase in all sequenced serovars of A. pleuropneumoniae
(see accession number WP_005603976), including the draft genomes of
the serovar 17 and 18 isolates from this study. The C-terminal portion
of the Cps17F protein (AAs 229–515) shares 94% identity with the 303
AA protein encoded by the final gene in the serovar 8 MIDG2331 CPS
locus, MIDG2331_01762 (Fig. 1), suggesting that the serovar 17 CPS
locus may have arisen by recombination of a gene encoding a predicted
expolysaccharide biosynthesis protein into the terminal gene of the
serovar 8 CPS locus, with deletion of the preceding two serovar 8 CPS
locus genes.
The serovar 18 isolates (Table 1; proposed reference strain
7311555) encode a type II CPS locus (Fig. 1B), with the first gene en-
coding a phosphotransferase sharing high identity with that encoded by
the first gene in the loci of serovars 1, 4, 12, 14, and to a lesser extent
with that of serovar 15 (Xu et al., 2010; Ito, 2015; Ito and Sueyoshi,
2015). The second gene in the serovar 18 locus encodes a 1115 AA
glycosyltransferase with only 32% identity to the 1247 AA glycosyl-
transferase encoded by the serovar 1 cpsB gene, although the first 23
AAs are identical in the two proteins. The final gene in the serovar 18
CPS locus encodes a 401 AA protein similar to the 406 AA protein
Fig. 1. Schematic representations of A.
pleuropneumoniae CPS biosynthetic loci. A)
The serovar 17 type I CPS biosynthetic locus
and comparison to that of the serovar 8 re-
ference strain, 405. The CPS biosynthesis
genes for serovar 17 (Sero 17;
cps17ABCDEF). The serovar 8 CPS biosyn-
thetic locus shares the first five genes as the
serovar 17 locus (99% identity at the nu-
cleotide level as indicated by the grey box
joining these genes), and contains three fur-
ther genes (each labelled hyp to indicate that
they encode hypothetical proteins), the last
of which shares 91% identity at the nucleo-
tide level with the 3′ end of the cps17F gene
(as indicated by the lighter grey parallelo-
gram). B) The serovar 18 type II CPS bio-
synthetic locus (cps18ABC) and comparison
to that of the serovar 1 reference strain, 4074
(cps1ABCD). The cpsA genes in these serovars
share 99% identity at the nucleotide level
(indicated by the grey box joining the genes),
whereas the cpsBC genes share less than 55% identity at the nucleotide level (indicated by the pale grey trapezoid joining these genes). The locations of serovar 17- and 18-specific
primers are indicated as small curved black arrows above cps17F and cps18B, respectively. The relative size and location of each gene are indicated by the sizes and positions of arrows
(solid dark gray). In all loci shown here, the CPS biosynthesis genes are located downstream of, and on the opposite strand to, the capsule export genes common to the loci in all A.
pleuropneumoniae serovars (cpxDCBA; only cpxD is shown).
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encoded by the cps1C gene, though they share only 41% identity. These
proteins contain an Asp2 superfamily domain found in Accessory Sec
system GspB-transporters of Gram positive bacteria. The serovar 18
CspC protein shares highest identity (55% over 361 AAs) with a pre-
dicted alpha/beta hydrolase from Cronobacter malonaticus (accession
number WP_032971501), whereas the serovar 1 CpsC shares highest
identity (68% over 387 AAs) with a predicted Accessory Sec system
GspB-transporter from Basfia succiniciproducens (accession number
SEP68412). The function of these CpsC proteins has yet to be de-
termined. In the serovar 1 CPS locus, there is an additional gene, cpsD,
encoding a 347 AA predicted acetyltransferase that is not present in the
serovar 18 locus.
Results of IHA using hyperimmune rabbit sera revealed homologous
reactivity (titer of 2560) of the serovar 17 antiserum with the proposed
reference strain (16287-1), with similar titers (+/- one dilution) for
other serovar 17 isolates, including 14-022, confirming both biovar 1
and biovar 2 isolates of serovar 17. Cross-reactivity (i.e. titers ≥640)
was also detected between serovars 17 and 8 (titer of 1280 for the
serovar 17 serum tested with the serovar 8 strain; but only a titer of 640
for the serovar 8 serum tested with the serovar 17 strain). In contrast,
the serovar 18 antiserum was highly specific, giving a titer of 10,240
with the proposed reference strain 7311555. These results are not
surprising given the genetic data showing more unique genes for the
serovar 18 locus, and the shared genes common to the CPS loci of
serovars 8 and 17.
We identified the O-antigen genes in the sequenced serovar 17 and
18 isolates, located between the erpA and rpsU genes, as previously
reported for other serovars of A. pleurpneumoniae (Xu et al., 2010).
BLASTn results for the serovar 17 O-antigen genes indicated 97–100%
identity (over 13,600 bp) with the loci in serovars 3, 6, 8, 15 (accession
numbers CP000687, ADOG00000000, LN908249, and AB743837, re-
spectively). Given that we only found serological cross-reactivity be-
tween serovar 17 and the serovar 8, it would appear that our IHA assay
detected antibodies directed against CPS antigens, but not O-antigens.
BLASTn analysis of the serovar 18 O-antigen genes revealed 97%
identity (over 11,340 bp) with the locus in serovar 7 (accession number
CP001091). Again, our IHA results did not show cross-reactivity be-
tween serovars 18 and 7, indicating that antibodies directed against
common O-antigens were not detected. However, it is likely that the
previous serological designation of ‘K2:O7’ for these isolates was due to
detection of O-antigen-specific antibodies.
For molecular diagnostics, we designed primers to amplify a unique
302 bp amplicon from the serovar 17 cpsF gene, and a unique 514 bp
amplicon from the serovar 18 cpsB gene. When multiplexed, along with
previously designed species-specific apxIV primers for detection of all
A. pleuropneumoniae serovars (Bossé et al., 2014), specific detection of
the serovar 17 and 18 amplicons was seen with the respective proposed
reference strains, with all of the other serovar reference strains only
amplifying the apxIV amplicon (Fig. 2). The specificity of the serovar 17
and 18 primers was further confirmed using the other sequenced ser-
ovar 17 and 18 isolates shown in Table 1, as well as DNA from clinical
isolates of A. pleuropneumoniae representing the 16 known serovars,
other bacteria associated with pigs, and by virtual PCR using genome
sequences available in Genbank, as previously described (Bossé et al.,
2017a).
PCR analysis of DNA samples from the isolates shown in Table 2
revealed that the recent biovar 2 NT isolates from the USA typed as
serovar 17, as did two of the recent biovar 1 Spanish isolates (4443 and
4461). These two Spanish isolates were initially typed as serovar 8 by
mPCR (Bossé et al., 2014), whereas all of the North American biovar 2
isolates were NT in this assay. These results indicate that some serovar
17 isolates share the cpsAB sequences targeted by what were thought to
be serovar 8-specific primers. Thus, in the past, some serovar 17 isolates
may have been molecularly typed as serovar 8, depending on the pri-
mers used, or serologically as 3/6/8 if the test used detected O-antigens.
Evidence supporting serovar 17 as separate from serovar 8 includes the
segregation of the Danish NT isolates by AFLP into the c17 cluster
distinct from serovar 8 isolates in c5 (Kokotovic and Angen, 2007); the
lack of apxIIIABCD genes normally found in serovar 8 (see below); and
the presence of only six CPS biosynthetic genes compared to eight genes
found in the CPS locus of serovar 8.
The previously NT isolates from Germany (2008), Italy (2011), and
the two Spanish NT isolates (APP199 and 4436; from 2004 and 2017,
respectively), typed as serovar 18, as did three additional’ K2:O7’ iso-
lates collected between 1996–2002. These’ K2:O7’ isolates included
15360/96 and 12323/98, that had been shown to form a distinct AFLP
cluster (c11), separate from other K2:O7 isolates found in cluster c8
(Kokotovic and Angen, 2007). Whereas the K2:O7 isolates in c8 were
found to produce amplicons for serovar 2, as well as serovar 8, when
tested in mPCRs (Jessing et al., 2003; Schuchert et al., 2004), those in
c11 only produced a species-specific omlA amplicon (Jessing et al.,
2003). The primer pair used by Schuchert et al. (2004) for detection of
serovar 8 was designed to amplify a 977 bp sequence from the cpsAB
genes which are common to serovars with type I CPS loci, with different
degrees of identity at the nucleotide level; whereas the serovar 2 primer
pair amplified region spanning the cpsCD genes, the latter being less
well conserved amongst type I CPS loci. Likewise, the serovar 2 primer
pairs used by Jessing et al. (2003) were designed to amplify a 504 bp
cpsD-specific region. Thus, the serovar 2 amplicon produced by the
K2:O7 isolates in AFLP cluster c8 is likely specific for the serovar 2 CPS
locus, whereas the serovar 8 amplicon is likely due to the presence of
common priming sites in the cpsAB genes.
The distribution of genes encoding Apx toxins I-III differ depending
on serovar, with some biovar 2 serovars showing different Apx toxin
profiles than their biovar 1 counterparts (Sthitmatee et al., 2003;
Rayamajhi et al., 2005; Maldonado et al., 2009). Toxin typing PCRs
have been used for characterizing isolates, since those producing ApxI
tend to be more highly virulent (Frey et al., 1995; Sthitmatee et al.,
2003; Rayamajhi et al., 2005; Maldonado et al., 2011). The serovar 17
and 18 isolates sequenced in the current study, regardless of biovar,
were all found to harbor only the genes required for production of ApxII
(apxIICA structural genes, and apxIBD export genes), a pattern similar
to that reported for biovar 1 serovars 7 and 12, as well as biovar 2
isolates of serovars 2, 4, 7, 11 and 13 (Frey et al., 1995; Rayamajhi
et al., 2005; Maldonado et al., 2009, 2011). A number of Spanish biovar
2 NT isolates were also reported to produce only ApxII (Maldonado
Fig. 2. Verification of specificity of primers for mo-
lecular identification of A. pleuropneumoniae serovars
17 and 18. An apxIV (418 bp) amplicon is detected in
all 18 serovar reference strains; the serovar 17-spe-
cific amplicon (302 bp) is detected only in the ser-
ovar 17 isolates (lanes 17, 17a); and the serovar 18-
specific amplicon (514 bp) is detected only in the
serovar 18 isolates (lanes 18, 18a). Lane M contains
molecular size markers (100 bp ladder). Lanes 1 to 18
contain samples from the following strains: 1, 4074T;
2, S1536; 3, S1421; 4, M62; 5, L20; 6, FemØ; 7,
WF83; 8, 405; 9, CVJ13261; 10, D13039; 11, 56153; 12, 8329; 13, N-273; 14, 3906; 15, HS143; 16, A-85/14; 17, 16287-1; 18, 7311555. Lane 17a contains the biovar 2 isolate, 14-022,
showing the same serovar 17 amplicon as the biovar 1 reference strain and other biovar 1 clinical isolates tested. Lane 18a contains serovar 18 isolate 7603757.
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et al., 2009, 2011). Testing of these isolates with our new mPCR would
determine if any belong to serovars 17 or 18.
In conclusion, we have used a combination of whole genome se-
quencing and serology to clarify the status of previously NT isolates, as
well as those previously mis-typed as ‘K2:O7’ (and unreactive in pre-
vious CPS-specific mPCRs), showing that they represent new serovars,
17 and 18 respectively, of A. pleuropneumoniae. Biovar 1 isolates of
serovar 17, first recovered in Denmark in 1997, appear to still be in
circulation in Europe, with a recent (2017) isolate from Spain identi-
fied. Whereas biovar 2 serovar 17 isolates have been recovered in North
America since 2014. Given the relatedness of the core cps and O-antigen
genes between serovars 8 and 17, it is possible that other isolates of
serovar 17 may have been typed as serovar 8 in the past. Serovar 18
isolates (biovar 1) have been in circulation in Europe since 1996, most
recently recovered in Spain in 2018. The PCR primers designed in this
study will help in further identification and epidemiological tracking of
these two newly designated serovars of A. pleuropneumoniae.
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